ML
VAXX

McAdam LLC’s Vaxxinity, Inc. Class A Common Stock VAXX Stock Holding History

McAdam LLC’s Portfolio VAXX Stock Details VAXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q2 		– Sell
-78,281
Closed -$56.2K – 336
2024
Q1 		$56.2K Hold
78,281
– – ﹤0.01% 292
2023
Q4 		$66.5K Buy
78,281
+10,000
+15% +$9.66K ﹤0.01% 272
2023
Q3 		$93.5K Buy
68,281
+21,957
+47% +$47.6K 0.01% 250
2023
Q2 		$117K Hold
46,324
– – 0.01% 253
2023
Q1 		$105K Buy
+46,324
New +$117K 0.01% 244

Other funds holding VAXX

SWM
Spire Wealth Management Mclean, Virginia $3.31B AUM 38.78% 1-Year Est. Return
XT
XTX Topco George Town, Cayman Islands $5.75B AUM 30.56% 1-Year Est. Return
CGL
Clarius Group LLC Seattle, Washington $1.75B AUM 19.04% 1-Year Est. Return
GT
Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return
FDCDDQ
Federation des caisses Desjardins du Quebec Levis, Quebec, Canada $27.8B AUM 31.66% 1-Year Est. Return
RF
Robinswood Financial Kirkland, Washington $349M AUM 14.9% 1-Year Est. Return

McAdam LLC's VAXX Position: Q2 2024 in Review

McAdam LLC sold out of Vaxxinity, Inc. Class A Common Stock (VAXX) in Q2 2024, closing a stake of 78,281 shares — an estimated $56.2K sold.

McAdam LLC first reported a position in VAXX in Q1 2023 and held it in 5 quarters. The position peaked at $117K in Q2 2023. 8 funds tracked by Wall St. Rank hold VAXX as of Q2 2024.

  • McAdam LLC reported no remaining Vaxxinity, Inc. Class A Common Stock position as of Q2 2024 after selling out during the quarter.
  • McAdam LLC sold 78,281 Vaxxinity, Inc. Class A Common Stock shares in Q2 2024, an estimated $56.2K.
  • McAdam LLC first reported a position in Vaxxinity, Inc. Class A Common Stock in Q1 2023 and held it in 5 quarters.
  • McAdam LLC's Vaxxinity, Inc. Class A Common Stock position peaked at $117K in Q2 2023.
  • 8 funds tracked by Wall St. Rank held Vaxxinity, Inc. Class A Common Stock as of Q2 2024.

Based on McAdam LLC's 13F filing for Q2 2024, filed 24 Jul 2024.